ResultsIQ › Latest results › Clean Science and Technology Limited
Clean Science and Technology Limited Q2 FY27 results deck summary
NSE: CLEAN · BSE: 543318
Results deck of 31 Oct 2026, summarised by AI from the filing.
Clean Science Q2 FY2027 consolidated revenue rose to ₹299 cr (+22%) while EBITDA margin fell to 31.2% on geopolitical headwinds.
Key takeaways
- Q2 revenue Consolidated total revenue was ₹299 cr (Q2 FY2026: ₹245 cr, +22%), with CFCL adding about ₹48 cr of year-on-year sales.
- HALS launch Commercial launch of advanced HALS products with Geneus Chem AG is expected in H2 FY2026–27 after trials met quality and regulatory standards.
- Margin moderation Consolidated EBITDA margin fell to 31.2% in Q2 FY2027 from 36.4% a year earlier as raw material expenses rose 33%.
- New segments HALS grew 2x in H1 FY2027 and now accounts for 22% of sales, while top four legacy products fell to ~58% from ~85% in Q4 FY23.
- Raw material Consolidated raw material expenses were ₹128 cr, 43.3% of revenue, up from 40.1% in Q2 FY2026.
Clean Science and Technology Limited Q2 FY27 results
As filed: Revenue ₹299 cr (+22% year on year), EBITDA ₹92.1 cr (+6% year on year), PAT ₹55.7 cr (+1% year on year), EBITDA margin 30.8% (−475 bps).
The Q2 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹268 cr (+10% year on year), EBITDA ₹96.4 cr (−5% year on year), PAT ₹73.4 cr (+5% year on year), EBITDA margin 35.9% (−564 bps). Score 52 of 100, In line with trend. Revenue and profit growth were in line with the company's own trend; EBITDA growth was below it. EBITDA margin fell 564 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +12.1% in 30 days (Nifty 500: 0.0%).
- Q4 FY26: Revenue ₹249 cr (−6% year on year), EBITDA ₹95.8 cr (−9% year on year), PAT ₹58.3 cr (−21% year on year), EBITDA margin 38.4% (−135 bps). Score 29 of 100, Below trend. Revenue and profit growth were well below the company's own trend; EBITDA growth was below it. EBITDA margin fell 135 bps year on year. Share price after the results: −5.8% in 29 days (Nifty 500: +1.0%).
- Q3 FY26: Revenue ₹220 cr (−9% year on year), EBITDA ₹72.2 cr (−26% year on year), PAT ₹45.9 cr (−30% year on year), EBITDA margin 32.9% (−780 bps). Score 14 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 780 bps year on year. Revenue fell 10% from last quarter. Share price after the results: −8.1% in 30 days (Nifty 500: −1.1%).
- Q2 FY26: Revenue ₹245 cr (+3% year on year), EBITDA ₹87.0 cr (−3% year on year), PAT ₹55.0 cr (−7% year on year), EBITDA margin 35.5% (−230 bps). Score 38 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin fell 230 bps year on year. Profit fell 21% from last quarter. Share price after the results: −9.5% in 29 days (Nifty 500: +1.4%).
- Q1 FY26: Revenue ₹243 cr (+8% year on year), EBITDA ₹101 cr (+6% year on year), PAT ₹70.0 cr (+6% year on year), EBITDA margin 41.6% (−85 bps). Score 52 of 100, In line with trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was above it. EBITDA margin fell 85 bps year on year. Revenue fell 8% from last quarter. Share price after the results: −18.3% in 28 days (Nifty 500: −3.2%).
- Q4 FY25: Revenue ₹264 cr (+16% year on year), EBITDA ₹105 cr (+11% year on year), PAT ₹74.0 cr (+6% year on year), EBITDA margin 39.8% (−189 bps). Score 56 of 100, In line with trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was above it. EBITDA margin fell 189 bps year on year. Share price after the results: +10.4% in 29 days (Nifty 500: +1.4%).
- Q3 FY25: Revenue ₹241 cr (+24% year on year), EBITDA ₹98.0 cr (+14% year on year), PAT ₹66.0 cr (+5% year on year), EBITDA margin 40.7% (−344 bps). Score 59 of 100, In line with trend. Revenue and EBITDA growth were above the company's own trend; profit growth was in line with it. EBITDA margin fell 344 bps year on year.
Past price moves after results do not indicate future moves. Not a recommendation.
Clean Science and Technology Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Earnings call (31 Oct 2026), Results deck (31 Oct 2026)
- Q1 FY27: Earnings call (1 Aug 2026), Results deck (1 Aug 2026)
- Q4 FY26: Earnings call (14 May 2026), Results deck (14 May 2026), Results deck (14 May 2026)
- Q3 FY26: Earnings call (31 Jan 2026), Results deck (31 Jan 2026)
- Q2 FY26: Earnings call (6 Nov 2025), Results deck (6 Nov 2025)
- Q1 FY26: Earnings call (17 Jul 2025), Results deck (17 Jul 2025)
- Q4 FY25: Earnings call (22 May 2025), Results deck (22 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.